Search
for
Sort by
Research 211–240 of 1000+
- Androgenic disorders of women: Diagnostic and therapeutic decision making
- Skin diseases in consequence of endocrine alterations
- The Effect of Parathyroid Hormones on Hair Follicle Physiology: Implications for Treatment of Chemotherapy-Induced Alopecia
- Cantú syndrome with coexisting familial pituitary adenoma
- New Biomarkers to Evaluate Hyperandrogenemic Women and Hypogonadal Men
- Androgenic Alopecia
- Adult Acne: Prevalence and Portrayal in Primary Healthcare Patients, in the Greater Porto Area, Portugal
- Testosterone in COVID-19 – Foe, Friend or Fatal Victim?
- Androgen Receptor in Human Health: A Potential Therapeutic Target
- Clinical review 74: Dermatological manifestations of endocrine disorders.
- Influence of Genotype and Hyperandrogenism on Sexual Function in Women With Congenital Adrenal Hyperplasia
- Comparative biology of tissue repair, regeneration and aging
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- Dermatologic manifestations of endocrine disorders
- The Evaluation and Management of Hirsutism
- The Biology of Hair Growth
- Testosterone Therapy in Premenopausal Women
- Facial preservation following extreme mummification: Shrunken heads
- Topical L‐thyroxine: The Cinderella among hormones waiting to dance on the floor of dermatological therapy?
- Increased DHEAS and Decreased Total Testosterone Serum Levels in a Subset of Men with Early-Onset Androgenetic Alopecia: Does a Male PCOS-Equivalent Exist?
- Treatment of androgen excess in females: Yesterday, today and tomorrow
- Focal and Generalized Alopecia
- ‘Disappearing Foot Disease’: An Unusual Presentation of Primary Lymphoma of Bone
- Alopecia: Association with Resistance to Thyroid Hormones
- Autoimmune gastritis and parietal cell reactivity in two children with abnormal intestinal permeability
- Kinetic topographical heterogeneity in follicular thyroid neoplasms and growth patterns
- Treatment of hyperandrogenism in women
- Androgenetic Alopecia
- Pharmacological Options for Treatment of Hyperandrogenic Disorders
- Do 5α-Reductase Inhibitors Raise Circulating Serum Testosterone Levels? A Comprehensive Review and Meta-Analysis to Explaining Paradoxical Results